Pathobiology and Clinical Management of T-cell Lymphoma
In session I of iwNHL 2018, Laurence de Leval, MD, delivers updates on pathology and genetics while Jurgen Ruland, PhD, discuss TCR signalling and PD1.
Institut universitaire de pathologie, Lausanne, Switzerland
Laurence de Leval, MD, from Institut universitaire de pathologie, Lausanne, Switzerland, gives an update on the pathology and genetics of T-cell lymphoma.
Technische Universität München, Munich, Germany
Jurgen Ruland, PhD, from Technische Universität München, Munich, Germany, talks about the mechanisms of T-cell receptor signalling in T-cell lymphomas.